Title: MORE Savings Act
Policy area: Health

Summary:
Maximizing Opioid Recovery Emergency Savings Act or the MORE Savings Act
This bill modifies coverage of opioid treatments and recovery support services under Medicare, Medicaid, and private health insurance.
Specifically, the bill requires the Center for Medicare and Medicaid Innovation to test a model in which specified opioid treatments and recovery support services are provided under Medicare without cost-sharing (e.g., coinsurance, copayments, and deductibles).
The bill also allows state Medicaid programs to cover recovery support services as part of medication-assisted treatment (MAT) and increases the applicable Federal Medical Assistance Percentage for MAT.
Private health insurers must also cover specified opioid treatments and MAT-associated recovery support services without cost-sharing.

[Congressional Bills 116th Congress]
[From the U.S. Government Publishing Office]
[H.R. 7627 Introduced in House (IH)]

<DOC>






116th CONGRESS
  2d Session
                                H. R. 7627

To promote affordable access to evidence-based opioid treatments under 
   the Medicare program and require coverage of medication assisted 
     treatment for opioid use disorders, opioid overdose reversal 
  medications, and recovery support services by health plans without 
                       cost-sharing requirements.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                             July 16, 2020

   Ms. Dean introduced the following bill; which was referred to the 
 Committee on Energy and Commerce, and in addition to the Committee on 
   Ways and Means, for a period to be subsequently determined by the 
  Speaker, in each case for consideration of such provisions as fall 
           within the jurisdiction of the committee concerned

_______________________________________________________________________

                                 A BILL


 
To promote affordable access to evidence-based opioid treatments under 
   the Medicare program and require coverage of medication assisted 
     treatment for opioid use disorders, opioid overdose reversal 
  medications, and recovery support services by health plans without 
                       cost-sharing requirements.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Maximizing Opioid Recovery Emergency 
Savings Act'' or the ``MORE Savings Act''.

SEC. 2. TESTING OF ELIMINATION OF MEDICARE COST-SHARING FOR EVIDENCE-
              BASED OPIOID TREATMENTS.

    Section 1115A(b)(2) of the Social Security Act (42 U.S.C. 
1315a(b)(2)) is amended--
            (1) in subparagraph (A), in the last sentence, by inserting 
        ``, and shall include the model described in subparagraph (D) 
        (which shall be implemented by not later than six months after 
        the date of the enactment of the Maximizing Opioid Recovery 
        Emergency Savings Act)'' before the period at the end; and
            (2) by adding at the end the following new subparagraph:
                    ``(D) Affordable access to evidence-based opioid 
                treatments.--
                            ``(i) In general.--The model described in 
                        this subparagraph is a model that seeks to 
                        provide affordable access to evidence-based 
                        opioid treatments and recovery support services 
                        by eliminating coinsurance, copayments, and 
                        deductibles otherwise applicable under parts B 
                        and D of title XVIII (including as such parts 
                        are applied under part C of such title) for the 
                        following items and services that are otherwise 
                        covered under such parts:
                                    ``(I) Drugs and biologicals 
                                prescribed or furnished to treat opioid 
                                use disorders or reverse overdose.
                                    ``(II) Behavioral health services 
                                furnished for the treatment of opioid 
                                use disorders.
                                    ``(III) Recovery support services 
                                to maintain a healthy lifestyle 
                                following opioid misuse treatment, such 
                                as peer counseling and transportation.
                            ``(ii) Selection of sites.--The CMI shall 
                        select 15 States in which to conduct the model 
                        under this subparagraph. A State shall meet 
                        each of the following criteria in order to be 
                        selected under the preceding sentence:
                                    ``(I) The State has a high 
                                proportion of Medicare beneficiaries.
                                    ``(II) The State has a high rate of 
                                overdose deaths due to opioids.
                                    ``(III) The State has a significant 
                                percentage of rural areas.
                            ``(iii) Termination and modification 
                        provision not applicable for first five years 
                        of the model.--The provisions of paragraph 
                        (3)(B) shall apply to the model under this 
                        subparagraph beginning on the date that is five 
                        years after such model is implemented, but 
                        shall not apply to such model prior to such 
                        date.''.

SEC. 3. COVERAGE OF OPIOID TREATMENTS.

    Title XXVII of the Public Health Service Act is amended by 
inserting after section 2719A (42 U.S.C. 300gg-19a) the following:

``SEC. 2720. COVERAGE OF OPIOID TREATMENTS.

    ``A group health plan and a health insurance issuer offering group 
or individual health insurance coverage shall, at a minimum, provide 
coverage for and shall not impose any cost-sharing requirements for--
            ``(1) prescription drugs for the treatment of opioid use 
        disorders or to reverse overdose;
            ``(2) behavioral health services for the treatment of 
        opioid use disorders; or
            ``(3) recovery support services that are provided in 
        conjunction with medication-assisted treatment for an opioid 
        use disorder, such as peer counseling and transportation, to 
        support the enrollee in maintaining a healthy lifestyle 
        following opioid misuse treatment.''.

SEC. 4. ENHANCED FEDERAL MATCH FOR MEDICATION-ASSISTED TREATMENT AND 
              RECOVERY SUPPORT SERVICES UNDER MEDICAID.

    (a) In General.--Section 1905(b) of the Social Security Act (42 
U.S.C. 1396d(b)) is amended by adding at the end the following: 
``Notwithstanding the first sentence of this subsection, the Federal 
medical assistance percentage shall be 90 percent with respect to 
amounts expended during the period described in subsection (a)(29) by a 
State that is one of the 50 States or the District of Columbia as 
medical assistance for medication-assisted treatment (as defined in 
subsection (ee)(1)).''.
    (b) State Option To Provide Recovery Support Services as Part of 
Medication-Assisted Treatment.--Section 1905(ee)(1) of the Social 
Security Act (42 U.S.C. 1396d(ee)(1)) is amended--
            (1) in subparagraph (A), by striking ``; and'' and 
        inserting a semicolon;
            (2) in subparagraph (B), by striking the period at the end 
        and inserting ``; and''; and
            (3) by adding at the end the following new subparagraph:
                    ``(C) at the option of a State, includes recovery 
                support services, such as peer counseling and 
                transportation, that are provided to an individual in 
                conjunction with the provision of such drugs and 
                biological products to support the individual in 
                maintaining a healthy lifestyle following opioid misuse 
                treatment.''.
                                 <all>